Oridonin enhances in vitro anticancer effects of lentinan in SMMC‑7721 human hepatoma cells through apoptotic genes

Xu,Tao; Jin,Fa; Wu,Keren; Ye,Zhipeng; Li,Ning

doi:10.3892/etm.2017.5168

Oridonin enhances in vitro anticancer effects of lentinan in SMMC‑7721 human hepatoma cells through apoptotic genes

Authors:
- Tao Xu
- Fa Jin
- Keren Wu
- Zhipeng Ye
- Ning Li
View Affiliations

Affiliations: Department of Hepatobiliary Surgery, The First Affiliated Hospital of Zhejiang Chinese Medical University, Hangzhou, Zhejiang 310005, P.R. China
Published online on: September 21, 2017 https://doi.org/10.3892/etm.2017.5168
Pages: 5129-5134

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The aim of the present study was to determine the ability of oridonin to enhance the anticancer activity of lentinan (LNT) in SMMC‑7721 human hepatoma cells in vitro by using various techniques, including MTT, flow cytometry, quantitative PCR and western blot assays. The results demonstrated that 20 µg/ml was a non‑toxic concentration of oridonin for L02 normal liver cells and SMMC‑7721 cells, while 0‑200 µg/ml of LNT only had anti‑proliferative effects on SMMC‑7721 cells. LNT at 100 and 200 µg/ml inhibited the growth of SMMC‑7721 cells by 22.8 and 60.0%, respectively, and after addition of 20 µg/ml oridonin, the inhibitory rate of 100 and 200 µg/ml LNT was increased to 47.2 and 80.7%, respectively. Oridonin (20 µg/ml) + LNT (200 µg/ml)‑treated SMMC‑7721 cells showed the highest apoptotic rate, which was 40.5±2.5%, which was higher than that of cells treated with LNT only. LNT raised the mRNA and protein expression of caspase‑3, ‑8 and ‑9 as well as B‑cell lymphoma 2 (Bcl‑2)‑associated X protein, p53 and p21, while reducing the expression of Bcl‑2, Bcl extra large protein, epidermal growth factor (EGF) and EGF receptor expression in SMMC‑7721 cells as compared to that in control cells. Treatment with 20 µg/ml oridonin and 200 µg/ml LNT increased these changes of gene expression. From the obtained results, it may be concluded that oridonin raised the in vitro anti‑cancer effects of LNT in SMMC‑7721 cells. Oridonin may also be used as a sensitizing agent to increase the anticancer activity of LNT in vivo.

View Figures

View References

1	Kupfahl C, Geginat G and Hof H: Lentinan has a stimulatory effect on innate and adaptive immunity against murine Listeria monocytogenes infection. Int Immunopharmacol. 6:686–696. 2006. View Article : Google Scholar : PubMed/NCBI
2	Hou XJ and Chen W: Optimization of extraction process of crude polysaccharides from wild edible BaChu mushroom by response surface methodology. Carbohyd Polym. 72:67–74. 2008. View Article : Google Scholar
3	Murata T, Hatayama I, Kakizaki I, Satoh K, Sato K and Tsuchida S: Lentinan enhances sensitivity of mouse colon 26 tumor to cis-diamminedichloroplatinum (II) and decreases glutathione transferase expression. Jpn J Cancer Res. 87:1171–1178. 1996. View Article : Google Scholar : PubMed/NCBI
4	Drandarska I, Kussovski V, Nikolaeva S and Markova N: Combined immunomodulating effects of BCG and Lentinan after intranasal application in guinea pigs. Int Immunopharmacol. 5:795–803. 2005. View Article : Google Scholar : PubMed/NCBI
5	Huang HL, Weng HY, Wang LQ, Yu CH, Huang QJ, Zhao PP, Wen JZ, Zhou H and Qu LH: Triggering Fbw7-mediated proteasomal degradation of c-Myc by oridonin induces cell growth inhibition and apoptosis. Mol Cancer Ther. 11:1155–1165. 2012. View Article : Google Scholar : PubMed/NCBI
6	Wang H, Yu HS and Xue HW: Radio sensitization effect of oridonin on HepG2 in vitro. Med J Qi Lu. 22:339–342. 2007.
7	Mullard A: Pioneering apoptosis-targeted cancer drug poised for FDA approval. Nat Rev Drug Discov. 15:147–149. 2016. View Article : Google Scholar : PubMed/NCBI
8	Denisenko TV, Sorokina IV, Gogvadze V and Zhivotovsky B: Mitotic catastrophe and cancer drug resistance: A link that must to be broken. Drug Resist Updat. 24:1–12. 2016. View Article : Google Scholar : PubMed/NCBI
9	O'Connor SE: Plant biochemistry. Fighting cancer while saving the mayapple. Science. 349:1167–1168. 2015. View Article : Google Scholar : PubMed/NCBI
10	Zhao X, Wang Q, Li GJ, Chen F, Qian Y and Wang R: In vitro antioxidant, anti-mutagenic, anti-cancer and anti-angiogenic effects of Chinese bowl tea. J Funct Food. 7:590–598. 2014. View Article : Google Scholar
11	Zhao X, Qian Y, Zhou YL, Wang R, Wang Q and Li GJ: Pu-erh tea has in vitro anticancer activity in TCA8113 cells and preventive effects on buccal mucosa cancer in U14 cells injected mice in vivo. Nutr Cancer. 66:1059–1069. 2014. View Article : Google Scholar : PubMed/NCBI
12	Suo H, Zhao X, Qian Y, Sun P, Zhu K, Li J and Sun B: Lactobacillus fermentum Suo attenuates HCl/ethanol induced gastric injury in mice through its antioxidant effects. Nutrients. 8:1552016. View Article : Google Scholar : PubMed/NCBI
13	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(Delta Delta C(T)) method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI
14	Wong RS: Apoptosis in cancer: From pathogenesis to treatment. J Exp Clin Cancer Res. 30:872011. View Article : Google Scholar : PubMed/NCBI
15	O'Donovan N, Crown J, Stunell H, Hill AD, McDermott E, O'Higgins N and Duffy MJ: Caspase 3 in breast cancer. Clin Cancer Res. 9:738–742. 2003.PubMed/NCBI
16	Rodríguez-Berriguete G, Galvis L, Fraile B, de Bethencourt FR, Martínez-Onsurbe P, Olmedilla G, Paniagua R and Royuela M: Immunoreactivity to caspase-3, caspase-7, caspase-8, and caspase-9 forms is frequently lost in human prostate tumors. Hum Pathol. 43:229–237. 2012. View Article : Google Scholar : PubMed/NCBI
17	Tsujimoto Y: Role of Bcl-2 family proteins in apoptosis: Apoptosomes or mitochondria? Gene Cell. 3:697–707. 1998. View Article : Google Scholar
18	Swanton E, Savory P, Cosulich S, Clarke P and Woodman P: Bcl-2 regulates a caspase-3/caspase-2 apoptotic cascade in cytosolic extracts. Oncogene. 18:1781–1787. 1999. View Article : Google Scholar : PubMed/NCBI
19	Park HJ, Jeon YK, You DH and Nam MJ: Daidzein causes cytochrome c-mediated apoptosis via the Bcl-2 family in human hepatic cancer cells. Food Chem Toxicol. 60:542–549. 2013. View Article : Google Scholar : PubMed/NCBI
20	Willis SN, Chen L, Dewson G, Wei A, Naik E, Fletcher JI, Adams JM and Huang DC: Proapoptotic Bak is sequestered by Mcl-1 and Bcl-xL, but not Bcl-2, until displaced by BH3-only proteins. Gene Dev. 19:1294–1305. 2005. View Article : Google Scholar : PubMed/NCBI
21	Xu SY, Xiao DJ, Luan YZ, Wang YS, Wang L and Shi K: Regulatory mechanism of cell cycle block and apoptosis in p53 mutated gastric cancer cells during cisplatin stress. J Shandong Univ (Health Sci). 46:478–480. 2008.
22	Moulin M, Carpentier S, Levade T and Arrigo AP: Potential roles of membrane fluidity and ceramide in hyperthermia and alcohol stimulation of TRAIL apoptosis. Apoptosis. 12:1703–1720. 2007. View Article : Google Scholar : PubMed/NCBI
23	Fuchs EJ, Mckenna KA and Bedi A: p53-dependent DNA damage-induced apoptosis requires Fas/APO-1-independent activation of CPP32beta. Cancer Res. 57:2550–2554. 1997.PubMed/NCBI
24	Klostergaard J, Leroux ME, Auzenne E, Khodadadian M, Spohn W, Wu JY and Donato NJ: Hyperthermia engages the intrinsic apoptotic pathway by enhancing upstream caspase activation to overcome apoptotic resistance in MCF-7 breast adenocarcinoma cells. J Cell Biochem. 98:356–369. 2006. View Article : Google Scholar : PubMed/NCBI
25	Woo SM, Choi YK, Kim AJ, Cho SG and Ko SG: p53 causes butein-mediated apoptosis of chronic myeloid leukemia cells. Mol Med Rep. 13:1091–1096. 2016. View Article : Google Scholar : PubMed/NCBI
26	Hollmann G, Linden R, Giangrande A and Allodi S: Increased p53 and decreased p21 accompany apoptosis induced by ultraviolet radiation in the nervous system of a crustacean. Aquat Toxicol. 173:1–8. 2016. View Article : Google Scholar : PubMed/NCBI
27	Deng W, Gu L, Li X, Zheng J, Zhang Y, Duan B, Cui J, Dong J and Du J: CD24 associates with EGFR and supports EGF/EGFR signaling via RhoA in gastric cancer cells. J Transl Med. 14:322016. View Article : Google Scholar : PubMed/NCBI
28	Appert-Collin A, Hubert P, Crémel G and Bennasroune A: Role of ErbB receptors in cancer cell migration and invasion. Front Pharmacol. 6:2832015. View Article : Google Scholar : PubMed/NCBI
29	Yen HY, Liu YC, Chen NY, Tsai CF, Wang YT, Chen YJ, Hsu TL, Yang PC and Wong CH: Effect of sialylation on EGFR phosphorylation and resistance to tyrosine kinase inhibition. Proc Natl Acad Sci USA. 112:pp. 6955–6960. 2015; View Article : Google Scholar : PubMed/NCBI